| Pharmaceutical active ingredients: |
| Ethinyl EstradiolNorethindrone Acetate |
| Available forms, composition and doses of Norlestrin: |
| Tablets; Oral-21; Ethinyl Estradiol 0.05 mg; Norethindrone Acetate 1 mgTablets; Oral-21; Ethinyl Estradiol 0.05 mg; Norethindrone Acetate 2.5 mgTablets; Oral-28; Ethinyl Estradiol 0.05 mg; Norethindrone Acetate 1 mg |
| Norlestrin medical category: |
| Human:Oral contraceptives |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| G03AA05 - Norethisterone and estrogenG03AB04 - Norethisterone and estrogenG03CA01 - Ethinylestradiol |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| PfizerParke-Davis |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Minovlar ED | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Neorlest | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Parke-Davis |
| Nevis | Ethinyl Estradiol; Norethindrone Acetate | Barr Laboratories |
| Non-Ovlon | Ethinyl Estradiol; Norethindrone Acetate | Jenapharm; Bayer Schering Pharma |
| Norethindrone; Ethinyl Estradiol | Ethinyl Estradiol; Norethindrone Acetate | Barr Laboratories |
| Orlest | Ethinyl Estradiol; Norethindrone Acetate | Pfizer; Parke-Davis |
| Ostro-Primolut | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Primosiston Tablets | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Progylut | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |
| Prosiston | Ethinyl Estradiol; Norethindrone Acetate | Bayer Schering Pharma |